Description: C4 Therapeutics, Inc. (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.
Home Page: www.c4therapeutics.com
CCCC Technical Analysis
490 Arsenal Way
Watertown,
MA
02472
United States
Phone:
617 231 0700
Officers
| Name | Title |
|---|---|
| Mr. Andrew J. Hirsch | CEO, Pres & Director |
| Dr. Kenneth C. Anderson M.D., Ph.D. | Co-Founder, Independent Director & Member of Scientific Advisory Board |
| Ms. Lauren A. White | Chief Financial Officer |
| Dr. Stewart Fisher | Chief Scientific Officer |
| Ms. Jolie M. Siegel J.D. | Chief Legal Officer |
| Dr. Adam S. Crystal M.D., Ph.D. | Chief Medical Officer |
| Dr. Nathanael S. Gray Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| Ms. Kendra Adams | Sr. VP of Communications & Investor Relations |
| Kristina Zambouras | Director of HR |
| Ms. Kelly Schick | Chief People Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.2079 |
| Price-to-Sales TTM: | 8.146 |
| IPO Date: | 2020-10-02 |
| Fiscal Year End: | December |
| Full Time Employees: | 121 |